A review of grants to four large cities means that HIV prevention services, COVID-19 care, and more could be cut.
An experimental HIV vaccine that led to increased risk of contracting the virus had similarities to some of the COVID-19 vaccines in development.
The pandemic is causing innumerable problems, including challenges to HIV prevention.
The drug, called CPT31, showed good results in monkeys and will soon be tested in humans.
Health care disparities affecting the Black community, including among Black LGBTQ+ people, must be addressed.
UnitedHealthcare will cease Descovy coverage in September, but generic Truvada will be covered at no out-of-pocket cost.
American Gene Technologies will begin trials in September in the Baltimore-Washington, D.C., metro area.
